Literature DB >> 5271290

Philadelphia chromosome in acute lymphocytic leukemia.

S Propp, F A Lizzi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5271290

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  A 50-year journey to cure childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

2.  Milestones in the curability of pediatric cancers.

Authors:  Melissa M Hudson; Michael P Link; Joseph V Simone
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

3.  Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells.

Authors:  P J Fialkow; A M Denman; R J Jacobson; M N Lowenthal
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

Review 4.  Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment.

Authors:  Juwina Wijaya; Tomoka Gose; John D Schuetz
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

5.  Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.

Authors:  A Grossman; R T Silver; Z Arlin; M Coleman; E Camposano; P Gascon; P A Benn
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

Review 6.  Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges.

Authors:  Simona Soverini; Renato Bassan; Thomas Lion
Journal:  J Hematol Oncol       Date:  2019-04-23       Impact factor: 17.388

Review 7.  Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Authors:  Claudio Cerchione; Franco Locatelli; Giovanni Martinelli
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

Review 8.  Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia.

Authors:  Govinda Poudel; Molly G Tolland; Timothy P Hughes; Ilaria S Pagani
Journal:  Cancers (Basel)       Date:  2022-07-06       Impact factor: 6.575

Review 9.  Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.

Authors:  Simona Soverini; Manuela Mancini; Luana Bavaro; Michele Cavo; Giovanni Martinelli
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.